• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Low-density lipoprotein receptor class A domain-containing protein 3 (LDLRAD3), Truncated

ACP15251

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15251 Target NameLDLRAD3
Target SynonymsLDLRAD3; LRAD3; Low-density lipoprotein receptor class A domain-containing protein 3; LDLR class A domain-containing protein 3FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ86YD5
Background Information
  • Uniprot Id

    Q86YD5

  • Target Species

    Human

  • Target Name

    LDLRAD3

  • Target Full Name

    Low-density lipoprotein receptor class A domain-containing protein 3

  • Target Function

    May influence APP processing, resulting in a decrease in sAPP-alpha production and increased amyloidogenic P3 peptide production.

  • Target Subcellular Location

    Cell membrane; Single-pass type I membrane protein.

  • Target Protein Families

    LDLR family

  • Target Tissue Specificity

    Expressed at high levels in brain, lung, skeletal muscle, and pancreas. Expressed at moderate levels in heart, placenta, and kidney but not detected in the liver.

  • Target Synonyms

    LDLRAD3; LRAD3; Low-density lipoprotein receptor class A domain-containing protein 3; LDLR class A domain-containing protein 3

Inquire Recombinant Human Low-density lipoprotein receptor class A domain-containing protein 3 (LDLRAD3), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification